- APDN Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
10-K/A Filing
Applied DNA Sciences (APDN) 10-K/A2013 FY Annual report (amended)
Filed: 1 May 14, 12:00am
(1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
/s/ Karol Kain Gray | ||
Karol Kain Gray | ||
Chief Financial Officer | ||
Date: May 1, 2014 |
* | A signed original of this written statement required by Section 906 has been provided to Applied DNA Sciences, Inc. and will be retained by Applied DNA Sciences, Inc. and furnished to the Securities and Exchange Commission or its staff upon request. |